Motivation: In genome-wide rate comparison studies, there is a big challenge for effective identification of an appropriate number of significant features objectively, since traditional statistical comparisons without multi-testing correction can generate a large number of false positives while multi-testing correction tremendously decreases the statistic power. Results: In this study, we proposed a new exact test based on the translation of rate comparison to two binomial distributions. With modeling and real datasets, the exact binomial test (EBT) showed an advantage in balancing the statistical precision and power, by providing an appropriate size of significant features for further studies. Both correlation analysis and bootstrapping tests demonstrated that EBT is as robust as the typical rate-comparison methods, e.g. v 2 test, Fisher's exact test and Binomial test. Performance comparison among machine learning models with features identified by different statistical tests further demonstrated the advantage of EBT. The new test was also applied to analyze the genome-wide somatic gene mutation rate difference between lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), two main lung cancer subtypes and a list of new markers were identified that could be lineage-specifically associated with carcinogenesis of LUAD and LUSC, respectively. Interestingly, three cilia genes were found selectively with high mutation rates in LUSC, possibly implying the importance of cilia dysfunction in the carcinogenesis. Availability and implementation: An R package implementing EBT could be downloaded from the website freely: http://www.szu-bioinf.org/EBT.
Introduction
Case-control studies play important roles in medical research and applications. Traditional phenotype-suspicious factor cohort studies have disclosed a large number of important disease risks (Davies et al., 2015; Emerging Risk Factors Collaboration, 2011; Klein et al., 2004; Stellman et al., 2001; Uemura et al., 2001) . Since the human genome was drafted, genome-wide association studies (GWAS) have been active, disclosing more and more genetic alleles with significantly high risk for various diseases (Capasso et al., 2009; CONVERGE consortium, 2015; Joshi et al., 2016 ; Malaria V C The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com Genomic Epidemiology Network, 2015; Morange et al., 2010) . These studies also provided a variety of biomarkers and therapeutic targets, which have important application potential in disease diagnosis, treatment and prevention. In the era of precision medicine, case-control studies are exerting more active roles, in disclosing more significant biological features associated with all aspects of medicine and facilitating more precise disease prevention, diagnosis and treatment guidance (Dai et al., 2012; Li et al., 2012; Weissfeld et al., 2015; White et al., 2016; Wu et al., 2015) . All these studies, however, involve a core analytic procedure, that is, the rate comparison of interesting features between cases and controls.
Chi-square (v 2 ) test has been adopted by almost each GWAS study. It is also predominantly used in other studies involving rate comparison. v 2 test was originally proposed in 1900, supposing that the observed populations followed a theoretical (expected) v 2 distribution (Yates, 1934) . The robustness of v 2 test is influenced by the total sample size or observed ratios in either case or control group, since the factors can influence the accuracy of modeling the theoretical distribution (Yates, 1934) . When the size of total samples or expected composition is small, the test needs to be corrected or replaced by another rate comparison model, Fisher's exact test (Fisher, 1922 ). Fisher's exact test translates the rate comparison problem into a hypergeometric distribution model, and has been widely used as a complementary strategy of v 2 test especially when the sample size is limited. When total samples or positive observations increase, the influence of overall-distribution uncertainty becomes more significant, and the Fisher's exact test becomes more inaccurate (Fisher, 1922) . Besides v 2 /Fisher's exact tests, binomial distribution-based tests have also been used for rate comparison (Wang et al., 2013 (Wang et al., , 2014 (Wang et al., , 2015 .
In GWAS, tens of thousands of factors, e.g. alleles, are often observed and compared simultaneously for the same samples. The accumulated type I errors in a single v 2 /Fisher's exact test or other rate-comparison test caused a large number of false positives (FPs). In practice, there are often hundreds to thousands of factors showing significant rate difference between cases and controls. To control the FPs, Bonferroni proposed a strict correction strategy by multiplying the single test P-values with a constant scaling factor, the testing times (Dunnett, 1955) . Benjamini and Hochberg (1995) loosened the Bonferroni correction, and suggested a false discovery rate (FDR) strategy to control the type I errors. These strategies effectively decreased the false positive rates (FPRs), and have been adopted widely. However, the low statistic power also became a major concern. With the multi-testing correction in GWAS studies, there were often too few or even no any significant factors identified; many false negatives (FNs) were out of detection (Sham and Purcell, 2014) . In recent years, various methods were proposed to increase the statistic power of rate comparison tests with multitesting correction, e.g. binning alleles into genes, pathways or networks to decrease the total number of observed factors (Freytag et al., 2013; Pan et al., 2015; Wu et al., 2010) . In classificationtargeted machine learning studies, feature selection is an important issue. The features are often identified by rate comparison between cases and controls due to the low computational cost. Feature number is also important, since the model performance is low when only a few atypical features are identified for use while the performance would also deteriorate strikingly if too many features are used (Mitchell, 1997) . Single tests without FP control in GWAS generate too many features while FP control leads to too few features, both not suitable for machine learning model training frequently. The binning strategies on original factors often dramatically increase the technical difficulty and costs in practical examination of the significant features. Some models only take the top tens to hundreds of significant factors with smallest P-values detected by single tests without FP control, but the feature number is arbitrary and the features are not guaranteed to be most effective (Ding et al., 2013; Kaplan and Morris, 2001) .
In this study, we proposed an exact binomial test (EBT), which also modeled the rate comparison question with a binomial distribution. It is stricter than traditional binomial distribution based tests so that the power is lowered. However, for a GWAS study comparing genes or alleles, the EBT can detect a moderate size of significant factors objectively compared with v 2 /Fisher's exact tests or traditional binomial tests with and without FDR control, which are suitable for further experimental investigation or being used as biomarkers or _features for effective prediction model training. To demonstrate the accuracy and reliability of EBT, both modeling and real datasets were tested and the results of different testing methods were compared. A bootstrapping strategy was also proposed to further examine the robustness of exact binomial testing results. As an application, genome-wide somatic gene mutation rates were compared between lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) with the new test, and a moderate size of genes were identified with significant difference between groups. We also used the features to build support vector machine (SVM) models that could effectively classify the two tumor subtypes, and demonstrated its better performance than the models trained with features identified with v 2 /Fisher's exact tests or binomial tests with or without FDR control.
Materials and methods

Somatic mutation and clinical datasets
The somatic mutation and clinical datasets of LUAD and LUSC were downloaded from The Cancer Genome Atlas (TCGA) (The Cancer Genome Atlas Research Network, 2012 . The mutations causing codon changes, frame-shifts, and premature translational terminations were retrieved for further analysis. For mutation rate comparison, each gene was considered as a unit and all nucleotides within the unit were binned. A mutated gene was defined if there was at least one mutation in the gene frame. Each interesting gene was examined in each patient whether it was mutated, and subsequently the gene mutation rate was calculated in the target population. For survival datasets, the 'days to death' based to stratify the 'Dead' subjects into the good (>3 years) and poor (<3 years) prognosis groups. For 'Alive' subjects, the 'days to last follow-up' were based, and only the ones with larger than 3 years were retrieved and integrated into the good prognosis group. In fact, there could be more 'Alive' subjects with a survival larger than 3 years but not included because of current uncertainty. The somatic mutation and prognostic datasets of prostate adenocarcinoma (PRAD) and LUAD were described in Supplementary Material.
The statistic model of modified EBT
Suppose population A and B, with a sample size of N A and N B , respectively. The number of individuals with an interesting characteristic (positive) is n a and n b for A and B, respectively. Let n a /N A ! n b / N B . The null hypothesis (H 0 
and B(N B , p B ) represent the binomial distribution with N A trials and a success rate of p A and that with N B trials and a success rate of p B , respectively. A joint probability, Prob joint could be calculated, based on the formula as below:
, where the two factors are conditional probabilities for the actual number of positive individuals (X or Y) being smaller than n a in a B(N A , p A ) distribution and larger than n b in a B(N B , p B ) distribution, respectively.
If the H 0 holds, Prob joint gets close to the minimum when p A ¼ p B ¼ p AB , and 1 À Prob joint represents the approximated maximal union probability of the four events:
H 0 (p A p B ) could be represented by the union of events (i)-(iv). Therefore, H 0 is rejected and the alternative H 1 is accepted if (1 À Prob joint ) < a; otherwise, H 0 cannot be rejected.
Due to the symmetry, a similar model, probability calculation and statistical inference could be made for n a /N A n b /N B .
For a given comparison (N A , N B , p AB , a), the power of a left-tail or right-tail EBT was computed with the expression revised from Krishnamoorthy (2006) :
where I(.) is the indicator function, and
2.3 v 2 test, Fisher's exact test and binomial distribution-based test v 2 tests and corrected v 2 tests (total sample size ! 40 and at least one expected frequency being located between 1 and 5) were performed, or replace by Fisher's exact tests (total sample size < 40 or at least one expected frequency being smaller than 1). For the two populations A and B described previously, and given n a /N A ! n b / N B , in traditional binomial distribution-based tests, either Prob(X ! n a j B(N A , p B )) or Prob(X < n b j B(N B , p A )) is calculated and represents the probability of the null hypothesis (p A < p B ). In practice, however, the two probabilities often differentiate with each other a lot, and the maximum likelihood estimation of p A or p B is often zero in many cases. Therefore, the binomial tests were modified slightly, for which the Prob(X < n a j B(N A , p AB )) and Prob(Y > n b j B(N B , p AB )) were calculated respectively, followed by calculation of the geometric mean that represented the final P-value. Geometric mean was calculated because binomial distributions belong to the exponential family and the probabilities could be presented as products of exponential factors. The definitions of N A , N B , n a , n b and p AB were described previously. Benjamini-Hochberg multi-testing correction was performed when required. The significance level (a) was set as 0.05.
Comparison of statistic power and precision of different tests
The power of EBTs was calculated with the formula shown in Section 2.2. The power of traditional binomial tests was calculated according to Krishnamoorthy (2006) . The power of tests with Benjamini-Hochberg correction was closely related with the practical datasets themselves and therefore Bonferroni correction was examined instead with a broad range of multiple test times (10-10 000). The power of v 2 tests was evaluated with G*Power (Faul et al., 2009) . Three groups of synthetic datasets were also generated with the procedure described in Supplementary Material to further evaluate the precision and/or power of different tests. Let TP, FP, TN, FN represent true positive, false positive, true negative and false negative, respectively, FPR, Precision and True Positive Rate (TPR) were calculated respectively with the following formulas, FPR ¼ FP/(FP þ TN), Precision ¼ TP/(TP þ FP) and TPR ¼ TP/(TP þ FN).
Boostrapping tests
Subsets of the populations A and B with randomly defined sample size (100-500 for the LUAD versus LUSC mutation dataset) were extracted randomly for 100 replicates, followed by independent EBTs, v 2 or Fisher's exact Tests and Binomial Tests each time. For each replicated experiment, the genes were ranked according to their P-values and the top n genes were recorded (n was set as 50 for the LUAD versus LUSC mutation dataset). For each kind of tests, the times of each gene ranked within the top n among all experiments were counted as testing scores and ordered. The bootstrapping scores (between 1 and 100) reflected the confidence on significance of the rate difference. The most significant n genes detected with a single statistical test were also compared with the top n genes detected most robustly (with largest scores). The mutual coverage also indicated the robustness of the single test.
SVMs and performance assessment
The n genes with lowest P-values for mutation frequency difference were used as the genetic features. For each case P j (j ¼ 1, 2,. . .,m i ) belonging to a certain category C i , where i equaled to 1 or 0, and m i represented the total number of cases of the category C i , the genetic features were represented as a binary vector
. ., n) represented the kth genetic feature, taking the value of 1 if the corresponding gene was mutated and 0 otherwise. There was an m i *n matrix for category C i . A training-testing strategy was adopted to evaluate the performance of models. Training-testing datasets were prepared according to the procedure described below. The original LUAD and LUSC samples were randomized respectively, followed by a 5-fold splitting of the data from each group. The combination of each 4-fold of the LUAD and LUSC data compromised a training dataset and the rest 1-fold comprised the corresponding testing dataset. Consequently, five pairs of training-testing datasets were constructed. Each training dataset was used for feature selection based on statistic tests or nonstatistic method mRMR (Ding and Peng, 2005) , and used for model training with optimized kernel and parameters. The corresponding testing dataset was used independently for evaluation of the model performance. Evaluations were based on the average results of all the five training-testing pairs for each kind of model. An R package, 'e1071', was used for training SVM models using each training dataset (http://cran.r-project.org). For each trainingtesting experiment, the training dataset was used for both kernel selection and parameter optimization. Four kernels, including 'radial' (Radial Base Function), 'linear', 'polynomial' and 'sigmoid', were individually tested for the best-optimized parameters with a 10-fold cross-validation grid search strategy. The range of parameters tested for the models were same, 2 À10 -2 for gamma ('radial', 'sigmoid'
and 'polynomial'), 2
À5
-2 5 for coef0 ('polynomial' and 'sigmoid') and 2
À2
-2 10 for all SVMs' cost. The performance of different kernels with best-optimized parameters was then compared and the best kernel (with optimal parameters) was selected for further model training and prediction on the testing dataset. Receiver operating characteristic (ROC) curve and the area under ROC curve (AUC) were utilized to assess the predictive performance. An ROC curve is a plot of Sensitivity versus (1 À Specificity) and is generated by shifting the decision threshold. AUC gives a relatively objective measure of classifier performance.
Results
Statistical power and precision of EBTs
The statistical power of EBTs was influenced by sample size, expected success rates of populations (p A and p B ) and significance cutoff (a). The power increases as sample size increases ( Fig. 1A and B) . The power also increases as the difference increases between expected success rates or a increases. For example, when the sample size was 70 and a was set as 0.05, the power of 0.45_versus_0.15 (p A _versus_ p B ) reached 0.85, and that of 0.25_versus_0.1 and 0.2_versus_0.1 were only 0.26 and 0.08, respectively (Fig. 1A) , while the power of 0.2_versus_0.1 increased to 0.38 when the a increased to 0.20 (Fig. 1B) . When the sample size increased to 600, the examined tests with different parameters all reached the highest power ( Fig. 1A and B) . Considering the relatively low frequencies and small rate difference in real genome-scale datasets and the frequently adopted type I error level in practice, 0.2_versus_0.1 and 0.05 were used as representative p A _versus_ p B and a level respectively for later performance evaluation and comparison of different tests ( Supplementary Fig. S1 , distribution of gene mutation rates; Greenman et al., 2009; Sham and Purcell, 2014) .
The power of traditional binomial tests with or without multitesting correction was also evaluated (Fig. 1C) . Traditional binomial tests without correction showed higher power than EBTs when the sample size was small (Fig. 1C) , though the superiority decreased as the difference of expected success rates (p A _versus_ p B ) decreased (data not shown). However, compared with binomial tests with multi-testing correction, EBTs showed much higher power (Fig. 1C) . In Figure 1C , binomial tests with only 10Â Bonferroni corrections showed apparently lower power. In practice, the multi-testing could be repeated for even larger than 10 000 frequently, and the power would decrease to an extreme low level (Supplementary Fig. S2 ). v 2 tests without correction showed a power close to that of traditional binomial tests, while v 2 tests with multi-testing correction was not analyzed because of the practical difficulty in calculation ( Supplementary Fig. S2 ). Although the power of EBTs was apparently improved when compared with traditional binomial tests with correction, the type I errors and FPR could increase and the precision decrease a lot, making the new test not useful practically. Therefore, synthetic datasets with well-controlled distributions and parameters were generated for FPR and precision analysis. Three different types of datasets were synthesized according to Supplementary Material and Supplementary Figure S1 . Datasets I represented an ideal situation of two source populations with fixed p A and p B for all genes, respectively, while Datasets II were more realistic since the real gene mutation rates were modeled for populations under comparison (Supplementary Fig. S1A and B) . The results of the two datasets were quite similar to each other. With a significance level of 0.05, the FPR of EBTs was consistently lower than that of binomial tests without multi-testing correction but close to them with correction ( Fig. 1D for Datasets II; Supplementary Fig. S3A for Datasets I). Accordingly, the precision of EBTs was close to that of binomial tests with correction and apparently higher than that of binomial tests without correction ( Fig. 1E; Supplementary Fig. S3B ). The v 2 tests with and without correction were also performed and evaluated for the FPR and precision, and the results were close to binomial tests with and without correction, respectively ( Supplementary  Fig. S4 ). It should be noted that the extremely low TPR (i.e. recall) of traditional tests with correction (approaching or equal to 0) led to the appeared larger difference between them and EBTs for FPR and precision when the sample size was small ( Fig. 1F ; Supplementary  Fig. S3C ). Therefore, the 'increased' precision of traditional tests with correction was at an expensive cost in the strikingly lowered power.
Genome sequencing datasets were also synthesized (Supplementary Material and Supplementary Fig. S1 Table S1 ). The precision and TPR could not be evaluated with the datasets because no gene with controlled mutation difference between groups was included (Supplementary Material and Supplementary Fig. S1 ). Taking together, the results indicated that the EBTs could improve the power of traditional tests with multi-testing correction but without apparent loss of precision. In other words, EBTs could make a better balance between types I and II errors in multiple rate comparisons, especially in genome-level studies that involve small success rates and more than 10 000 times of comparisons.
Empirical comparison with v
2 /Fisher's exact tests with or without multi-testing correction
The TCGA mutation datasets of lung cancers were used as real datasets for further performance evaluation of EBTs. Among the 17 424 protein-encoding genes with mutations at least in one LUAD or LUSC case, the EBTs detected 45 with significantly different mutation rates between LUAD and LUSC (P < 0.05; Fig. 2A ; Supplementary Table S2 ). With v 2 or Fisher's exact tests, 483 genes showed significance for the mutation rate difference (P < 0.05; Fig.  2A ; Supplementary Table S2 ). Considering the high FPR among the large number of genes with significant difference by multiple singlegene tests, a Benjamini-Hochberg correction was performed and consequently generated a list of 16 genes with the control of a false discovery rate (FDR) (FDR < 0.05; Fig. 2A ; Supplementary Table  S2 ). Based on these results, when compared with v 2 and Fisher's exact tests with or without correction, the EBTs appeared to generate a moderate size of statistically significant results with an objective preset cutoff. Though being with high FPRs themselves and with a low power when multi-testing correction was performed, v 2 and Fisher's exact tests still gave relatively accurate results and therefore widely adopted. The significant genes identified by EBTs were therefore further compared with the significant ones detected with v 2 and
Fisher's exact tests with or without correction. As shown in Figure  2A , the 45 significant genes tested by EBTs were all detected in the 483 significant results of v 2 and Fisher's exact tests, and covered all the 16 significant ones identified by multi-testing corrected v 2 and
Fisher's exact tests. Meanwhile, the top ranked 45 genes with the smallest v 2 and Fisher's exact test P-values were retrieved. These genes happened to be mutually covered by those significant ones detected by EBTs ( Fig. 2A) . For these 45 genes, the significance ranks were compared between the two types of tests (EBT versus v 2 /
Fisher's exact test), and a high correlation was observed (Spearman Correlation Coefficient, SCC, 0.94; Fig. 2B ).
We also compared the methods with additional two datasets: the LUAD and LUSC 3-year prognosis datasets. For the LUAD prognosis dataset, v 2 tests or Fisher's exact tests with and without multitesting correction detected 36 and 0 genes with significantly different mutation rates between populations of >3-year (n ¼ 60) and <3-year survival (n ¼ 57), respectively. With EBTs, only three genes (ADAMTS5, LYST and PTPRC) showed significance, and all the three genes were also ranked most significantly in the results of v 2 / Fisher's exact tests (Supplementary Table S3 ). For the LUSC prognosis dataset, however, both v 2 /Fisher's exact tests with multi-testing correction and EBTs did not detect any significant gene between the populations with > 3-year (n ¼ 79) and < 3-year survival (n ¼ 79), and therefore the consistence of significant results between different tests could not be directly compared. The gene with the lowest EBT P-value (DUSP27, P ¼ 0.06), however, was also ranked as the most significant gene with v 2 /Fisher's exact tests (Supplementary Table S4 ). For both datasets, the composition and significance ranks showed high consistency for the genes with lowest P-values between EBTs and v 2 /Fisher's exact tests (Supplementary Tables S3 and S4) . Taking together, the results demonstrated that the EBT generated results as accurate as v 2 or Fisher's exact test, but strikingly lowered the FPR of the latter without multi-testing correction and increased the positive discovery rate of the latter with multi-testing correction.
Empirical comparison with binomial tests with or without multi-testing correction
The EBT results were also compared with those of traditional binomial tests. With binomial tests, in total, 215 genes were detected with significant mutation rate difference between LUAD and LUSC (P < 0.05), and only one gene (KRAS) remained significant after FDR control (FDR < 0.05) ( Fig. 3A ; Supplementary Table S2) . The 215 significant genes detected by binomial test without multi-testing correction completely covered the 45 significant genes detected by EBTs, and the only significant KRAS gene after correction was also included in the significant list of EBTs (Fig. 3A) . The top 45 genes with lowest P-values tested by traditional binomial tests were retrieved and compared with the significant list of EBTs. Around 76% (34/45) of them were overlapped with each other (Fig. 3B) . The P-values of the 34 common genes were ordered in the resulting list of either type of test, and a relatively low correlation; however, was observed for the gene significance ranks between the two test methods (SCC ¼ 0.41; Fig. 3C ).
The two additional datasets with smaller data sizes (117 for LUAD and 158 for LUSC 3-year prognosis dataset) were also used for comparison of the EBTs and traditional binomial tests. In total, 8 and 1 significant genes were detected from LUAD and LUSC prognosis dataset with traditional binomial tests, respectively. No significant Tables S3 and S4 ). The three significant genes detected with EBTs (ADAMTS5, LYST and PTPRC) from the LUAD dataset were also covered by traditional binomial testing results with lowest P-values, and the only significant gene detected with traditional binomial tests (DUSP27) from the LUSC dataset was exactly the one with the lowest P-value detected by EBTs (Supplementary  Tables S3 and S4 ). The composition and significance ranks were quite conserved for the genes with lowest P-values among EBTs, traditional binomial tests and v 2 /Fisher's exact tests, implicating the high consistency for the different statistical methods for datasets with smaller data size (Supplementary Tables S3 and S4 ).
Robustness of EBTs
Above results demonstrated the possible advantages of EBTs in balancing FP (precision) and FN (power) rates, generating a moderate size of interesting features for further analysis or application, and maintaining a general accuracy close to that of commonly used v 2 tests, Fisher's exact tests or binomial tests. The robustness and capability of generalization of testing results were further evaluated.
Bootstrapping tests were developed and performed for the gene mutation rate comparison between LUAD and LUSC. The robustness of the three types of tests was pretty similar to each other (Table 1) . Three genes, KRAS, TP53 and TTN were always stably detected with a bootstrapping score of > 90, while the top significant 50 genes with highest confidence were all with a score no less than 25 ( Fisher's exact tests, higher than the 41 genes (82%) consistent between EBTs and binomial tests; the ranks also showed higher consistence between EBTs and v 2 or Fisher's exact tests (Table 1) .
Different gene mutation profile between LUAD and LUSC
Above analysis demonstrated the advantages of EBT over the traditional tests with or without multi-testing correction, in providing more significant results at low FP risks. Therefore, a comprehensive comparison of gene mutation rates was made between LUAD and LUSC with the EBT. A total of 149 and 141 genes had missense, non-sense or frameshifting mutations in larger than 10% LUAD and LUSC patients, respectively, 95 among which were common between the two different tumor subtypes. Most of the genes with high mutation rates did not show significant rate difference between LUAD and LUSC (90/ 95, $95%, EBT, P > 0.05, Supplementary Table S5 ). These genes could represent the common mechanisms associated with LUAD and LUSC carcinogenesis and progression. There were only 5 genes (DNAH11, MLL2, SYNE1, TP53 and TTN) showing significant rate difference between LUAD and LUSC, despite the high frequency in both tumor subtypes. All of these five genes mutated more frequently in LUSC (Table 2; Supplementary Table S6 and S7) .
There were six genes (KRAS, NBPF10, FRG1B, TCRA, FAM75A6 and STK11) highly mutated (>10%) in the LUAD population but showing no or very low mutation rates (<2%) in the LUSC population (EBT, P < 0.05, Table 2 ). Additional five genes (OTOGL, UBC, KIR2DL2, OR8U8 and RGPD4) showed moderate mutation rates (5-10%) in LUAD but significantly lower rates (<1%) in LUSC (EBT, P < 0.05, Table 2 ). Among these 11 genes, KRAS mutations are well known as driver mutations and important in LUAD carcinogenesis (T ım ar, 2014) . Another gene STK11, also named as LKB1, was recently shown to function in transdifferentiation of LUAD to LUSC (Han et al., 2014; Li et al., 2015) . The rest 9 genes were newly identified, some of which were associated with other tumors (Supplementary Table S6 and S7). Their mutations could also be closely related with LUAD subtype-specific tumor development and progression.
Besides the five highly mutated genes in both LUAD and LUSC, there were 9 genes (NFE2L2, SLCO1B3, CDKN2A, PIK3CA, LRRK2, MDN1, FN1, SCN1A and ROS1) highly mutated (>10%) in LUSC and lowly mutated (2-5%) in LUAD, and 20 other genes (DPPA4, NUCB2, SCARF1, CADPS2, APOBEC1, NADSYN1, PTEN, ACSM4, CARS, ATP10A, STON1-GTF2A1L, MTMR3, PRR23B, VCPIP1, SLC13A1, ASCL4, IQCJ-SCHIP1, DNAI1, IPO11, ZDHHC17) moderately or lowly mutated in LUSC but still with significantly higher mutation rates than in LUAD (EBT, P < 0.05, Table 2 ). Among these genes, TP53, NFE2L2, CDKN2A, PIK3CA, PTEN and MLL2 were frequently found with high mutation rates in LUSC or other lung cancers (Kim et al., 2013 (Kim et al., , 2014 The Cancer Genome Atlas Research Network, 2012 Yin et al., 2014) . TTN, SYNE1 and ROS1 were recently reported to mutate widely and associate with lung cancers (Cagle et al., 2016; Kim et al., 2013) . The rest genes could also be associated with LUSC carcinogenesis or progression (Supplementary  Table S6 and S7). Three of them were particularly interesting (DNAH11, SLCO1B3 and DNAI1), all of which participate in dynein protein synthesis and cilia function directly (Beckers et al., 2007; Failly et al., 2008; Storm Van's Gravesande and Omran, 2005) . The dysfunction of cilia could be lineage-specifically associated with LUSC.
Application of EBT on feature selection for machine learning
One of the potential applications of the statistical methods on rate comparison could be the selection of effective features for training machine learning models. Therefore, we observed the capability of EBT in such an application in classification of LUAD and LUSC based on somatic gene mutation data, and compared it with other methods. KRAS  99  KRAS  99  KRAS  99  TP53  97  TP53  98  TP53  98  TTN  92  TTN  95  TTN  93  NBPF10  85  NBPF10  85  TCRA  89  NFE2L2  81  FRG1B  83  FRG1B  87  FRG1B  81  NFE2L2  81  NBPF10  86  TCRA  78  TCRA  81  FAM75A6  85  FAM75A6  77  FAM75A6  77  NFE2L2  80  DPPA4  76  DPPA4  75  DPPA4 Note: The gene mutually covered by the top significant 50 genes detected from the orginal dataset with individual statistical method was shown with gray background; the genes mutually covered by different statistical methods were shown in italic.
A 5-fold training-testing strategy was adopted to assess the performance of models. For each training dataset, the indicated number of genes (10, 20, 30, 40, 50, 100, 150 and 200) with lowest P-values for mutation rate difference between LUAD and LUSC population detected with different statistical methods were used as features for SVM model training, respectively. As shown in Figure 4A and B, the models based on features selected with EBTs (models) consistently outperformed those based on features identified with traditional statistical methods with or without multi-testing correction (CHI2, CHI2.FDR, BINOM and BINOM.FDR models). When feature size was small, the performance of models often increased as feature size increased ( Fig. 4A and B) . EBT, CHI2 and CHI2.FDR all reached the best performance at 40 features with AUC of 0.89, 0.87 and 0.87, respectively, while BINOM and BINOM.FDR models reached best at 20 and 30 features, respectively, with AUC of 0.83 and 0.74 ( Fig. 4A and B) .
A classical multivariate filtering method, mRMR, was also used for feature selection and model training to classify LUAD and LUSC. The model based on mRMR features also performed better as size increased and reached summit at 40 features with an AUC of 0.91, two percentages better than the best EBT model (Fig. 4C) . However, when the feature size was smaller (e.g. 10, 20 and 30, especially 10), EBT models outperformed mRMR ones ( Fig. 4C ; AUC of 0.82 versus 0.77 between mRMR versus EBT for 10 features). When more features (>40) were included, the performance of mRMR models deteriorated linearly, and EBT models apparently outperformed mRMR ones when 150 or more features were used (Fig. 4C) .
The statistic methods and mRMR were also applied in feature selection in a PRAD prognosis dataset, with the purpose of training models to predict the prognosis of PRAD ('good' or 'poor') using somatic gene mutation information (Supplementary Material). Supplementary Fig. S5 ). For this dataset, mRMR appeared not better than EBT for different feature size (mRMR best AUC: 0.63 at 50 features; Supplementary Fig. S5 ).
Besides the datasets studied earlier, the advantage of EBT in feature selection for classification over the 'top N' strategy based on the results of traditional tests was further demonstrated with two independent LUAD prognosis datasets (Supplementary Material). First, similar as before, a 5-fold training-testing strategy was used to optimize the models with varied size of features and evaluate the performance for the TCGA dataset (Supplementary Material; Supplementary Table S9) . When the top 30 or 50 features were selected, the EBT models outperformed CHI2 or BINOM ones significantly ( Supplementary Fig. S6A ). EBT identified 16 genes in the TCGA dataset with significant somatic mutation rates generally (Supplementary Table S10 ); the EBT model trained with these 16 genes was tested in another dataset (Imielinski) and compared with the BINOM and CHI2 models based on corresponding top 16 genes. As shown in Supplementary Figure S6B , the EBT model also showed better performance than either BINOM or CHI2 model.
Taking together, compared with other statistic tests, EBTs could generate a moderate size of significant features in genome-wide rate comparison studies that could be used to train machine learning models with better performance. For some datasets (e.g. PRAD prognosis), or with a small ( 10) or large (!150) size of features, EBT models could even outperform mRMR models. EBT also appeared better in providing more effective features for classification than traditional tests with 'top N' strategy.
Discussion
Rate comparison is important for GWAS studies, precision medicine application and feature selection of machine learning. v 2 and
Fisher's exact tests remain the predominantly used methods.
A variety of correction strategies such FDR were proposed for type I error control (Benjamini and Hochberg, 1995; Dunnett, 1955) . However, the increased precision is always accompanied by lowered power, vice versa. To increase statistic power without compromise of precision, in genome-wide studies, binning strategies were proposed (Freytag et al., 2013; Pan et al., 2015; Wu et al., 2010) . These methods did detect more significant results without change of 'precision'; however, in fact, they just made the interesting targets more unspecified. In this study, we proposed a new EBT. Theoretical calculation and synthetic datasets demonstrated that the power of EBT was lower than that of traditional binomial or v 2 /Fisher tests but much higher than that of traditional binomial test with multi-testing correction for small sample size ( Fig. 1C and F; Supplementary Fig.  S3C and S4C ). The precision of EBT, however, was much higher than that of traditional tests and very close to that of traditional tests with multi-testing correction ( Fig. 1D and E ; Supplementary  Figs. S3A , B, S4A and B; Supplementary Table S1) . Therefore, at a low cost of precision loss when compared with traditional tests with multi-testing correction, EBT could greatly improve the statistic power, a major challenge in current genome-wide studies (Sham and Purcell, 2014) . Multiple real datasets further confirmed the balancing effect of EBT between statistic power and precision, providing a moderate size of significant results, much smaller than those of binomial or v 2 /Fisher tests and larger than those of traditional tests with multi-testing correction. Bootstrapping robustness tests were also performed to demonstrate the high accuracy of EBT (Table 1) . Different from traditional one-sided binomial test, the EBT model translated a rate comparison question into two binomial distributions and calculated the joint distribution probability. Onesided binomial test took a sample success rate in one group as the expected rate, followed by a binomial modeling with the samples in the other group (Wang et al., 2013 (Wang et al., , 2014 (Wang et al., , 2015 . When the sample size or the success rate is small, the approximation of expected success rate would fluctuate a lot and the testing appeared inaccurate. EBT approximated the expected success rate (or expected H 0 proportion) with the average sample success rate of both groups, calculated the H 0 union regions of the two groups, and then found the rejected area. It is therefore much stricter and more robust than onesided binomial test. The strictness of EBT itself could reduce the risk of type I errors largely and therefore the testing results reached high precision without any control over the false discovery rate. In practice, the test should be used without FDR control to achieve the balancing effect demonstrated in this research.
The most important application of the new test could be to facilitate the identification of new interesting biological findings with high confidence and experimental feasibility. Taking the somatic mutation comparison between LUAD and LUSC as an example. Traditional v 2 /Fisher tests and binomial tests identified 483 and 215 genes with significant mutation rate difference respectively ( Figs. 2A  and 3A) . The large size of significant features increased the difficulty in further experimental investigations and risks of experimental failure caused by FPs. After FDR control, there were 16 and 1 genes remained respectively, however ( Figs. 2A and 3A) . Moreover, a majority of the significant results (if not all) were not new findings (Supplementary Tables S6 and S7) . EBT, however, identified 45 significant genes, among which known targets were mostly covered and there were also new findings (Table 2) . Although theoretical modeling, synthetic datasets-based analysis and bootstrapping tests demonstrated the high precision of the exact binomial testing results, experiments are still desired to confirm the observations; on the other hand, however, the moderate size of interesting targets ensured the feasibility of biological experiments. Among the 45 significant genes detected with EBT, 11 were selectively highly mutated in LUAD but lowly in LUSC, including the famous driver mutation gene in LUAD, KRAS. Interestingly, another differentially mutated gene, STK11, was confirmed by recent reports on the important function on transdifferentiation of LUAD to LUSC (Han et al., 2014; Li et al., 2015) . For the other genes, there is also indirect evidence on their specific function in the LUAD subtype of lung cancers. For example, NBPF10 was recently noticed with overexpression lineage-specifically in LUAD (Zhang et al., 2015) . FRG1B also showed tumor lineage-specific mutation patterns (Supplementary  Table S6 ). Given the high mutation rates in LUAD but considerably low occurrence of mutations in LUSC, the rest genes newly identified in this study are also interesting, which could play a particularly important role in LUAD pathogenesis. Other genes were with higher mutation rates in LUSC, including five genes that also frequently mutate in LUAD. TP53 is one of the genes most well-known for loss of function in a variety of tumors. Among the selectively highly mutated genes in LUSC, three of them, DNAH11, SLCO1B3 and DNAI1, encode dynein proteins and play direct roles in cilia function (Supplementary Table S5 ; Beckers et al., 2007; Failly et al., 2008; Storm Van's Gravesande and Omran, 2005) . A recent study reported the dysregulation patterns of cilia gene expression in different tumors (Shpak et al., 2014) . Other studies also suggested the cilia dysfunction in lung carcinogenesis (Chandra et al., 2015) . It remains to investigate how cilia dysfunction could be associated with lung carcinogenesis and especially LUSC.
Besides the application in new knowledge finding, we also tested the capability of EBT in feature selection for machine learning applications. With two examples, models classifying LUAD and LUSC subtypes and models predicting the prognosis of PRAD both based on genome-wide gene somatic mutation information, we found EBT almost always outperformed traditional tests with or without FDR control ( Fig. 4A and B; Supplementary Fig. S5 ). Therefore, EBT could be advantageous over these traditional tests in selection of features for model training. We also compared EBT with a popular multivariate filter, mRMR ( Fig. 4C; Supplementary Fig. S5 ). The multivariate filters try to reduce the feature information redundancy and therefore improve the model performance (Guyon and Elisseeff, 2003) . If the features show little correlation with each other, the filters could not represent their advantages. This could explain the observation of weaker performance of mRMR models compared with EBT models in the LUAD-LUSC classification dataset when feature size is small (e.g. 10), since the few genes could have small information redundancy with each other (Fig. 4C ). In such a situation, the relevance of individual features plays important roles. The consistently poorer performance of mRMR models than EBT ones in PRAD prognosis prediction could also be explained by the low correlation between feature pairs (Supplementary Fig. S5 ). The general mutation rates of PRAD cases were low (Supplementary Table S8) , and the information redundancy among the genes appeared lower. Taking together, conclusion could not be drawn that EBT is better or worse than mRMR, other multivariate filters or wrappers such as SVM-RFE (Guyon et al., 2002) in selection of features for machine learning application, but instead EBT provides a good option. For a specific feature selection application, EBT could be tried together with other approaches, for different feature size, followed by the selection of most effective ones.
